Department of Rehabilitation and Aged Care, Caulfield Hospital, The Alfred, Melbourne, Victoria, Australia; Department of Medicine, Peninsula Health, Melbourne, Victoria, Australia.
Pharmacy Department, The Alfred, Melbourne, Victoria, Australia.
J Am Med Dir Assoc. 2021 Jan;22(1):90-95. doi: 10.1016/j.jamda.2020.10.015. Epub 2020 Nov 15.
To determine the effect of introducing an electronic medication management system (EMMS) on deprescribing practice in a post-acute hospital setting.
This study used a before-after study design.
This study examined the admission and discharge medications prescribed to patients admitted to an Australian post-acute hospital before and after the introduction of an EMMS.
Data were collected over a 1-month period before and after the introduction of an EMMS and included summary measures of drug burden including Potentially Inappropriate Medications and the Drug Burden Index. We calculated and compared admission and discharge medication prescription as well as change in medication use before and after the introduction of an EMMS.
Medication prescription data were available for 121 people before and 107 people after EMMS introduction. In both phases, when compared with admission, those discharged were prescribed fewer medications (mean reduction pre-EMMS = 2.9, P < .001, post-EMMS = 2.6, P < .001), fewer Potentially Inappropriate Medications (mean reduction pre-EMMS = 0.4, P < .001, post-EMMS = 0.6, P < .001) and had lower Drug Burden Index (mean reduction pre-EMMS = 0.1, P < .001, post-EMMS = 0.2, P < .001). The degree of reduction in each measure was similar before and after EMMS introduction.
The introduction of an EMMS did not affect deprescribing practice in a post-acute hospital setting. Future work is required to explore the potential for clinical decision support within an EMMS to further improve the safety and effectiveness of deprescribing within post-acute care.
确定在急性后期医院环境中引入电子药物管理系统(EMMS)对减少用药的影响。
本研究采用前后研究设计。
本研究检查了在引入 EMMS 前后澳大利亚急性后期医院收治患者的入院和出院药物。
在引入 EMMS 前后收集了为期 1 个月的数据,包括药物负担的综合指标,包括潜在不适当药物和药物负担指数。我们计算并比较了引入 EMMS 前后的入院和出院药物处方以及药物使用的变化。
在引入 EMMS 前后,有 121 人的药物处方数据可用,107 人可用。在两个阶段,与入院时相比,出院时的处方药物较少(EMMS 引入前平均减少 2.9,P<0.001,EMMS 引入后平均减少 2.6,P<0.001),潜在不适当药物较少(EMMS 引入前平均减少 0.4,P<0.001,EMMS 引入后平均减少 0.6,P<0.001),药物负担指数较低(EMMS 引入前平均减少 0.1,P<0.001,EMMS 引入后平均减少 0.2,P<0.001)。引入 EMMS 前后,每种措施的减少程度相似。
在急性后期医院环境中引入 EMMS 并没有影响减少用药的实践。需要进一步研究在 EMMS 中使用临床决策支持的潜力,以进一步提高急性后期护理中减少用药的安全性和有效性。